Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gossamer Bio (GOSS) Shares Outstanding (Weighted Average): 2018-2024

Historic Shares Outstanding (Weighted Average) for Gossamer Bio (GOSS) over the last 7 years, with Dec 2024 value amounting to $226.6 million.

  • Gossamer Bio's Shares Outstanding (Weighted Average) rose 0.51% to $227.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $227.4 million, marking a year-over-year increase of 0.51%. This contributed to the annual value of $226.6 million for FY2024, which is 0.53% up from last year.
  • According to the latest figures from FY2024, Gossamer Bio's Shares Outstanding (Weighted Average) is $226.6 million, which was up 0.53% from $225.4 million recorded in FY2023.
  • In the past 5 years, Gossamer Bio's Shares Outstanding (Weighted Average) registered a high of $226.6 million during FY2024, and its lowest value of $75.9 million during FY2020.
  • In the last 3 years, Gossamer Bio's Shares Outstanding (Weighted Average) had a median value of $225.4 million in 2023 and averaged $182.2 million.
  • Data for Gossamer Bio's Shares Outstanding (Weighted Average) shows a peak YoY spiked of 138.59% (in 2023) over the last 5 years.
  • Yearly analysis of 5 years shows Gossamer Bio's Shares Outstanding (Weighted Average) stood at $75.9 million in 2020, then climbed by 0.71% to $76.5 million in 2021, then rose by 23.56% to $94.5 million in 2022, then skyrocketed by 138.59% to $225.4 million in 2023, then climbed by 0.53% to $226.6 million in 2024.